FindTrial
Sign In

Taurine supplementation

DIETARY_SUPPLEMENT5 trials

Sponsors

Kawasaki Medical School Hospital, University of Sao Paulo, University of Central Lancashire Cyprus, York University

Conditions

Browning of Subcutaneous White Adipose Tissue Post InterventionLong COVID SyndromeMetabolic and Inflammatory Variables Post InterventionTaurinemotochondrial encephalomyopathy (MELAS)

Phase 3

A multicentre trial of KN01 in patients with mitochondrial encephalomyopathy (MELAS)
Active, not recruitingJPRN-UMIN000011908
Kawasaki Medical School Hospitalmotochondrial encephalomyopathy (MELAS)
Start: 2013-10-03Target: 15Updated: 2026-06-29
A multicentre, long-term administration study of KN01 in patients with mitochondrial encephalomyopathy(MELAS)
Active, not recruitingJPRN-UMIN000015538
Kawasaki Medical School Hospitalmotochondrial encephalomyopathy (MELAS)
Start: 2014-10-02Target: 10Updated: 2026-06-29

Unknown Phase

Taurine Supplementation Associated or Not With Exercise: Effect on Browning of White Adipose Tissue in Elderly Women With Sarcopenic Obesity
NCT05415176
University of Sao PauloBrowning of Subcutaneous White Adipose Tissue Post Intervention, Metabolic and Inflammatory Variables Post Intervention
Start: 2023-02-27End: 2024-06-01Updated: 2023-11-29
Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power
CompletedNCT06884566
University of Central Lancashire CyprusTaurine
Start: 2025-01-07End: 2025-01-21Updated: 2025-03-19
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
RecruitingNCT07312409
York UniversityLong COVID Syndrome
Start: 2026-06-01End: 2027-12-31Target: 30Updated: 2026-06-05

Related Papers

1751-P: Physical Exercise Associated or Not with Taurine Supplementation—Impacts on Metabolic Health in Older Women with Sarcopenic Obesity
Diabetes2025-06-13
1787-P: Taurine Supplementation Combined with Multicomponent Training Reduces Adipocyte Area in Older Women with Sarcopenic Obesity
Diabetes2025-06-13
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial
Journal of Neurology Neurosurgery & Psychiatry2018-04-17131 citations